TMPRSS2
Transmembrane protease, serine 2 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||||
Symbols | TMPRSS2 ; PRSS10 | ||||||||||
External IDs | Template:OMIM5 Template:MGI HomoloGene: 4136 | ||||||||||
| |||||||||||
RNA expression pattern | |||||||||||
File:PBB GE TMPRSS2 205102 at tn.png | |||||||||||
File:PBB GE TMPRSS2 211689 s at tn.png | |||||||||||
More reference expression data | |||||||||||
Orthologs | |||||||||||
Template:GNF Ortholog box | |||||||||||
Species | Human | Mouse | |||||||||
Entrez | n/a | n/a | |||||||||
Ensembl | n/a | n/a | |||||||||
UniProt | n/a | n/a | |||||||||
RefSeq (mRNA) | n/a | n/a | |||||||||
RefSeq (protein) | n/a | n/a | |||||||||
Location (UCSC) | n/a | n/a | |||||||||
PubMed search | n/a | n/a |
Transmembrane protease, serine 2, also known as TMPRSS2, is a human gene.[1]
This gene encodes a protein that belongs to the serine protease family. The encoded protein contains a type II transmembrane domain, a receptor class A domain, a scavenger receptor cysteine-rich domain and a protease domain. Serine proteases are known to be involved in many physiological and pathological processes. This gene was demonstrated to be up-regulated by androgenic hormones in prostate cancer cells and down-regulated in androgen-independent prostate cancer tissue. The protease domain of this protein is thought to be cleaved and secreted into cell media after autocleavage. The biological function of this gene is unknown.[1]
References
Further reading
- Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. PMID 8125298.
- Paoloni-Giacobino A, Chen H, Peitsch MC; et al. (1997). "Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3". Genomics. 44 (3): 309–20. doi:10.1006/geno.1997.4845. PMID 9325052.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K; et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. PMID 9373149.
- Lin B, Ferguson C, White JT; et al. (1999). "Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2". Cancer Res. 59 (17): 4180–4. PMID 10485450.
- Hattori M, Fujiyama A, Taylor TD; et al. (2000). "The DNA sequence of human chromosome 21". Nature. 405 (6784): 311–9. doi:10.1038/35012518. PMID 10830953.
- Vaarala MH, Porvari KS, Kellokumpu S; et al. (2001). "Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues". J. Pathol. 193 (1): 134–40. doi:10.1002/1096-9896(2000)9999:9999<::AID-PATH743>3.0.CO;2-T. PMID 11169526.
- Afar DE, Vivanco I, Hubert RS; et al. (2001). "Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia". Cancer Res. 61 (4): 1686–92. PMID 11245484.
- Jacquinet E, Rao NV, Rao GV; et al. (2001). "Cloning and characterization of the cDNA and gene for human epitheliasin". Eur. J. Biochem. 268 (9): 2687–99. PMID 11322890.
- Teng DH, Chen Y, Lian L; et al. (2001). "Mutation analyses of 268 candidate genes in human tumor cell lines". Genomics. 74 (3): 352–64. doi:10.1006/geno.2001.6551. PMID 11414763.
- Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
- Gerhard DS, Wagner L, Feingold EA; et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334.
- Wilson S, Greer B, Hooper J; et al. (2005). "The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells". Biochem. J. 388 (Pt 3): 967–72. doi:10.1042/BJ20041066. PMID 15537383.
- Soller MJ, Isaksson M, Elfving P; et al. (2006). "Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer". Genes Chromosomes Cancer. 45 (7): 717–9. doi:10.1002/gcc.20329. PMID 16575875.
- Tomlins SA, Mehra R, Rhodes DR; et al. (2006). "TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer". Cancer Res. 66 (7): 3396–400. doi:10.1158/0008-5472.CAN-06-0168. PMID 16585160.
- Yoshimoto M, Joshua AM, Chilton-Macneill S; et al. (2006). "Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement". Neoplasia. 8 (6): 465–9. doi:10.1593/neo.06283. PMID 16820092.
- Böttcher E, Matrosovich T, Beyerle M; et al. (2006). "Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium". J. Virol. 80 (19): 9896–8. doi:10.1128/JVI.01118-06. PMID 16973594.
- Cerveira N, Ribeiro FR, Peixoto A; et al. (2006). "TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions". Neoplasia. 8 (10): 826–32. doi:10.1593/neo.06427. PMID 17032499.
- Yoo NJ, Lee JW, Lee SH (2007). "Absence of fusion of TMPRSS2 and ETS transcription factor genes in gastric and colorectal carcinomas". APMIS. 115 (3): 252–3. doi:10.1111/j.1600-0463.2007.apm_652.x. PMID 17367471.
- Winnes M, Lissbrant E, Damber JE, Stenman G (2007). "Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer". Oncol. Rep. 17 (5): 1033–6. PMID 17390040.
- Tu JJ, Rohan S, Kao J; et al. (2007). "Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues". Mod. Pathol. 20 (9): 921–8. doi:10.1038/modpathol.3800903. PMID 17632455.
This article on a gene on human chromosome 21 is a stub. You can help Wikipedia by expanding it. |